Colorado Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,327
Closed -$181K 74
2020
Q4
$181K Sell
2,327
-58
-2% -$4.44K 0.13% 72
2020
Q3
$189K Sell
2,385
-768
-24% -$60.2K 0.16% 68
2020
Q2
$230K Buy
3,153
+390
+14% +$29.4K 0.2% 68
2020
Q1
$202K Sell
2,763
-1,191
-30% -$93.6K 0.19% 68
2019
Q4
$343K Buy
3,954
+70
+2% +$5.75K 0.24% 58
2019
Q3
$312K Sell
3,884
-787
-17% -$63.1K 0.23% 61
2019
Q2
$374K Buy
4,671
+751
+19% +$57.5K 0.28% 59
2019
Q1
$311K Buy
+3,920
New +$293K 0.23% 61

Other funds holding MRK

Colorado Capital Management's MRK Position: Q1 2021 in Review

Colorado Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 2,327 shares — an estimated $181K sold.

Colorado Capital Management first reported a position in MRK in Q1 2019 and held it in 8 quarters. The position peaked at $374K in Q2 2019. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Colorado Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Colorado Capital Management sold 2,327 Merck shares in Q1 2021, an estimated $181K.
  • Colorado Capital Management first reported a position in Merck in Q1 2019 and held it in 8 quarters.
  • Colorado Capital Management's Merck position peaked at $374K in Q2 2019.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Colorado Capital Management's 13F filing for Q1 2021, filed 21 Apr 2021.